We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Church & Dwight (CHD) Q1 Earnings & Revenues Beat Estimates
Read MoreHide Full Article
Church & Dwight Company Inc. (CHD - Free Report) develops, manufactures and markets a broad range of household, personal care and specialty products. The company came out with first-quarter 2018 results wherein adjusted earnings of 63 cents per share came ahead of the Zacks Consensus Estimate of 61 cents and also increased 21.2% from the prior-year quarter.
Management projects adjusted earnings for second-quarter 2018 at 46 cents per share, depicting a growth of 12.2%. For 2018, the company continues to expect adjusted earnings in the band of $2.24-$2.28 per share.
Earnings Estimate Revision: The Zacks Consensus Estimate for 2018 has remained stable in the last 30 days. In the trailing four quarters, excluding the quarter under review, the company outperformed the Zacks Consensus Estimate by an average of 6.6%.
Church & Dwight Co., Inc. Price, Consensus and EPS Surprise
Revenues: Church & Dwight generated total sales of $1,006 million that increased 14.7% year over year and came ahead of the Zacks Consensus Estimate of $979 million. Organic sales increased 3.8%. Management forecasts second quarter net sales to increase 12%, while organic sales are expected to increase roughly 3%. Further, it expects 2018 net sales and organic sales to increase by nearly 9% and 3%, respectively.
Check back later for our full write up on Church & Dwight earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Church & Dwight (CHD) Q1 Earnings & Revenues Beat Estimates
Church & Dwight Company Inc. (CHD - Free Report) develops, manufactures and markets a broad range of household, personal care and specialty products. The company came out with first-quarter 2018 results wherein adjusted earnings of 63 cents per share came ahead of the Zacks Consensus Estimate of 61 cents and also increased 21.2% from the prior-year quarter.
Management projects adjusted earnings for second-quarter 2018 at 46 cents per share, depicting a growth of 12.2%. For 2018, the company continues to expect adjusted earnings in the band of $2.24-$2.28 per share.
Earnings Estimate Revision: The Zacks Consensus Estimate for 2018 has remained stable in the last 30 days. In the trailing four quarters, excluding the quarter under review, the company outperformed the Zacks Consensus Estimate by an average of 6.6%.
Church & Dwight Co., Inc. Price, Consensus and EPS Surprise
Church & Dwight Co., Inc. Price, Consensus and EPS Surprise | Church & Dwight Co., Inc. Quote
Revenues: Church & Dwight generated total sales of $1,006 million that increased 14.7% year over year and came ahead of the Zacks Consensus Estimate of $979 million. Organic sales increased 3.8%. Management forecasts second quarter net sales to increase 12%, while organic sales are expected to increase roughly 3%. Further, it expects 2018 net sales and organic sales to increase by nearly 9% and 3%, respectively.
Zacks Rank: Church & Dwight currently carries a Zacks Rank #3 (Hold), which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Church & Dwight earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>